-
- 抗原 See all CD69 抗体
- CD69
-
适用
- 小鼠
-
宿主
-
Armenian Hamster
-
克隆类型
- 单克隆
-
标记
- This CD69 antibody is conjugated to Biotin
-
应用范围
- Flow Cytometry (FACS)
- 品牌
- BD Pharmingen™
- 产品特性
-
The H1.2F3 antibody reacts with CD69 (Very Early Activation antigen), an 85 kDa disulfide-linked homodimer of differentially glycosylated subunits. CD69 is a C-type lectin, most closely related to the NKR-P1 and Ly-49 NK cell-activation molecules. Its expression is rapidly induced upon activation of lymphocytes (T, B, NK, and NK-T cells), neutrophils, and macrophages. CD69 is expressed also on thymocytes that are undergoing positive selection, its role in that process is unclear. H1.2F3 mAb augments PMA-induced T-cell stimulation and IFN-γ-induced macrophage stimulation. IL-2-activated NK cells express CD69, and H1.2F3 mAb induces redirected lysis of FcR-bearing target cells by NK cells. This antibody is routinely tested by flow cytometric analysis. Other applications were tested during antibody development only or reported in the literature.
BD Pharmingen™ Biotin Hamster Anti-Mouse CD69 - Biotin - Clone H1.2F3 - Isotype Armenian Hamster IgG1, λ3 - Reactivity Ms - 0.5 mg - 纯化方法
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
- 免疫原
- Mouse Dendritic Epidermal T Cell Line Y245
- 克隆位点
- H1-2F3
- 亚型
- IgG1 lambda
- Top Product
- Discover our top product CD69 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 浓度
- 0.5 mg/mL
- 缓冲液
- Aqueous buffered solution containing ≤0.09 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- The antibody was conjugated with biotin under optimum conditions, and unreacted biotin was removed.
- 储存条件
- 4 °C
- 储存方法
- Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
-
-
Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice." in: Blood, Vol. 95, Issue 7, pp. 2312-20, (2000) (PubMed).
: "Regulation of lineage commitment distinct from positive selection." in: Science (New York, N.Y.), Vol. 286, Issue 5442, pp. 1149-53, (1999) (PubMed).
: "Recent thymic emigrants are distinct from most medullary thymocytes." in: European journal of immunology, Vol. 27, Issue 8, pp. 2010-5, (1997) (PubMed).
: "Expression and function of the early activation antigen CD69 in murine macrophages." in: Journal of leukocyte biology, Vol. 62, Issue 3, pp. 349-55, (1997) (PubMed).
: "How many thymocytes audition for selection?" in: The Journal of experimental medicine, Vol. 186, Issue 7, pp. 1149-58, (1997) (PubMed).
: "Lineage commitment in the thymus: only the most differentiated (TCRhibcl-2hi) subset of CD4+CD8+ thymocytes has selectively terminated CD4 or CD8 synthesis." in: The Journal of experimental medicine, Vol. 184, Issue 6, pp. 2091-9, (1997) (PubMed).
: "Positive selection of thymocytes involves sustained interactions with the thymic microenvironment." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 155, Issue 11, pp. 5234-40, (1995) (PubMed).
: "The activation antigen CD69." in: Stem cells (Dayton, Ohio), Vol. 12, Issue 5, pp. 456-65, (1995) (PubMed).
: "Regulation of RAG-1 and CD69 expression in the thymus during positive and negative selection." in: European journal of immunology, Vol. 24, Issue 1, pp. 145-51, (1994) (PubMed).
: "The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 152, Issue 3, pp. 1228-36, (1994) (PubMed).
: "Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 150, Issue 2, pp. 673-82, (1993) (PubMed).
: "Activation events during thymic selection." in: The Journal of experimental medicine, Vol. 175, Issue 3, pp. 731-42, (1992) (PubMed).
: "Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 146, Issue 10, pp. 3662-73, (1991) (PubMed).
: "Very early (VEA) and very late (VLA) activation antigens have distinct functions in T lymphocyte activation." in: Immunological reviews, Vol. 109, pp. 153-76, (1989) (PubMed).
: "Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 141, Issue 2, pp. 369-76, (1988) (PubMed).
: "
-
Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice." in: Blood, Vol. 95, Issue 7, pp. 2312-20, (2000) (PubMed).
-
- 抗原
- CD69
- 别名
- CD69 (CD69 产品)
- 别名
- 5830438K24Rik antibody, AI452015 antibody, AIM antibody, VEA antibody, BL-AC/P26 antibody, CLEC2C antibody, EA1 antibody, GP32/28 antibody, MLR-3 antibody, Cd69 molecule antibody, CD69 antigen antibody, CD69 molecule antibody, Cd69 antibody, CD69 antibody
- 背景
- Synonyms: Very Early Activation antigen
-